LEYRE
URIGÜEN ECHEVERRIA
INVESTIGADOR/A DOCTOR/A PERMANENTE
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (9)
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2016
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575
2005
-
Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies
Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563
-
Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain
Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626
-
κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice
European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110
2004
-
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973
-
Role of endocannabinoid system in mental diseases
Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224
2002
-
Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies
Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153